
Keywords: AAR, Area at risk; CK-MB, Phosphocreatine kinase isoenzymes CKM and CKB; HIF1, Hypoxia induced factor 1; IL-R, Interleukin receptor; IL-18BP, IL-18 binding protein; LVEF, Left ventricular ejection fraction; EDV, End diastolic volume; MMP, Matrix metallopr